Pier Paolo Fattori

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 569 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +9

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.

Ilaria Panzini, Lorenzo Gianni, Pier Paolo Fattori et al. · PubMed · 2002 · 198 citations

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti et al. · The Lancet Oncology · 2014 · 182 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +9

Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.

Pier Luigi Zinzani, Maurizio Martelli, M Bertini et al. · PubMed · 2002 · 181 citations

Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.

Pier Luigi Zinzani, Enzo Pavone, Sergio Storti et al. · PubMed · 1997 · 163 citations